March 6th, 2014

Pharmaceutical companies' DC marketing efforts increase to nearly $98 million

By George Washington University School of Public Health and Health Services
Eureka Alert

Drug companies spent $97.5 million marketing pharmaceuticals in the District of Columbia in 2012, with $30.5 million (31.3%) of that spending taking the form of payments and gifts to physicians, hospitals, and other healthcare providers, according to a report by researchers at the George Washington University School of Public Health and Health Services (SPHHS).

These expenditures represent the first year-on-year spending increase by drug companies since 2007. Between 2007 and 2011, spending declined each year to a low of $84 million in 2011. The 2012 increase was driven by a jump in gifts, which include grants, speaker fees, food, and promotional items valued at more than $25. Companies gave a total of $19.6 million to hospitals, clinics, universities, and other organizations. That amount is nearly twice the $10.8 million received by physicians and other individuals.
“Pharmaceutical companies may be focusing on organizational rather than individual gifts as physician gift disclosure becomes more prevalent,” said Susan F. Wood, PhD, lead researcher and an associate professor of health policy and of environmental and occupational health at SPHHS.

Read more: http://www.eurekalert.org/pub_releases/2014-03/gwus-pcd030514.php

Comments

Add your own Comment

(optional)